GILEAD SCIENCES, INC. — Director's Dealing 2015

Aug 4, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-07-31

Reporting Person: Carter Paul Rutherford (EVP Commercial Ops)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-31	Common Stock	M	2500	$0.00	Acquired	50132	Direct
2015-07-31	Common Stock	F	1349	$117.860000	Disposed	48783	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-31	Restricted Stock Unit	$	M	2500	Acquired		Common Stock (2500)	Direct

Footnotes

F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock

F2: The restricted stock units vest 25% annually over a four year period after the date of grant.